Navigation Links
Baxa Corporation Launches Call for Research Papers
Date:3/28/2008

ENGLEWOOD, Colo., March 28 /PRNewswire/ -- Baxa Corporation announces a call for research papers involving its new PadLock(R) Set Saver product. The PadLock device is designed to promote best practice for aseptic IV administration set storage; preventing contamination of the administration set when disconnected from the patient. The recently released product provides temporary storage of the IV administration line between drug administrations, replacing the need for single-use, sterile caps. Baxa is offering several unrestricted grants for research studies on the usage and benefits of its new product. Grants will be awarded for research intended for presentation at the INS, AVA, APIC or similar meetings and/or publication in the Journal of Infusion Nursing, Journal of Vascular Access, American Journal of Infection Control or similar publications.

"We are interested in objective research studies on areas of interest to healthcare providers, such as cost-benefit studies, aseptic techniques and best practices," says Megan Kleckner, Product Manager of the announcement. "Research studies regarding compliance with best practice and the reduction of infection risks are also key targets." Professionals interested in pursuing the grants should submit contact information and research ideas via email to responses@baxa.com. Submissions will be reviewed and applicants responded to by Baxa Corporation in a timely manner.

Baxa Corporation is a world leader in developing innovative technology for the safe handling, packaging and administration of fluid medications in hospital and alternate-care settings. Renowned for enhancing patient safety and improving processes within pharmacy settings, with the PadLock Set Saver, Baxa brings its expertise and experience to the patient bedside.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Beatrice Community Hospital and Health Center Selects Zix Corporation for Email Encryption Service
2. CRH Medical Corporation opens new center in Denver, Colorado
3. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
4. Toxikon Corporation to Hold Medical Device and Testing Seminar Next Month
5. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
6. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
7. CRH Medical Corporation opens new Center in Miami, Florida
8. Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007
9. Alsius Corporation Receives Regulatory Approval in China and Mexico
10. Health Care Service Corporation Receives National Recognition for Employee Wellness Efforts
11. Response Biomedical Corporation Moves to New Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving compilation of ... value to God. “Letters From Home” is the creation of published author, John Allred, ... Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on four continents. ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg freezing and embryo ... embryos have a slight statistical advantage for live births, frozen eggs offer many ... for women undergoing medical treatment or who are concerned about the decline of ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... With ... so fun and easy to do. Users can select from up to two layers ... with a click of a mouse all within Final Cut Pro X. ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
(Date:9/21/2017)... ... 21, 2017 , ... The American Addiction Treatment Association (AATA) ... in the addiction treatment industry entitled: Special Investigations Unit (SIU) – What ... state and federal governments are increasingly scrutinizing the addiction treatment industry for fraudulent ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 7, 2017 NuvoAir (formerly called Pond ... today a partnership with Novartis Pharma AG to distribute NuvoAir,s ... as the leading mobile spirometry platform and Novartis, commitment to ... ... ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... Del. , Sept. 6, 2017 NeuroRx, a ... Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast ... its sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 ... in a pivotal trial of this sequential therapy targeting patients ... depression. 1 ...
Breaking Medicine Technology: